Millions of Brits are now eligible for the appetite-suppressing jabs which can come with unpleasant side effects - but NHS rationing means only a tiny fraction will be prescribed them ...

NHS semaglutide spending in London has surged from £242K in 2019 to £15.6m in 2024. Find out what's driving demand and the ...

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...

The pharmacy association said it was worried some patients were accessing the drugs inappropriately amid a surge in demand.

“Taking these medications puts individuals at risk of everything from allergic reactions to uncontrolled blood sugar levels, ...

We believe quality journalism should be available to everyone, paid for by those who can afford it. Popular weight loss drugs ...

Pharmacists say they are aware of people being wrongly prescribed the drugs who have previously had eating disorders, or ...

The drugs, which include Mounjaro, Ozempic and Wegovy, have ushered in a new era in the battle against obesity, helping dieters shed up to a fifth of their bodyweight. But American doctors — who ...

The rules over who can access weight loss jabs puts patients safety at risk, warns the National Pharmacy Association amid a ...

Losing excess weight would in turn improve health. For example, lower levels of sleep apnoea – when breathing stops and ...

Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it ...

The National Pharmacy Association (NPA) has written to regulators calling for tougher rules over access to medications like ...